Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biochemical Pharmacology

• Publication date

  1984-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-2952(84)90154-0PMID 6508822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

  2004cited by this paper
• Induction of Hamster Hepatic Peroxisomal β-oxidation and Peroxisome Proliferation-associated 80000 mol. wt. Polypeptide by Hypolipidemic Drugs

  1982cited by this paper
• Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.

  1982cited by this paper
• Inhibition of membrane-bound hepatic 3 hydroxy-3 methyl glutaryl CoA reductase as the consequence of altered membrane fluidity.

  1981cited by this paper
• Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.

  1981cited by this paper
• Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.

  1980cited by this paper
• Improved enzymatic assays for bile acids using resazurin and NADH oxidoreductase from Clostridium kluyveri.

  1980cited by this paper
• Purification of clofibrate-induced carnitine acetyltransferase from rat liver mitochondria.

  1980cited by this paper
• Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate.

  1980cited by this paper
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

  1980cited by this paper
• [Fenofibrate: animal toxicology in relation to side-effects in man (author's transl)].

  1980cited by this paper
• Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug.

  1979cited by this paper
• Rat liver peroxisomes catalyze the beta oxidation of fatty acids.

  1978cited by this paper
• Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.

  1977cited by this paper
• A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

  1976cited by this paper
• Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate

  1975cited by this paper
• PEROXISOMES IN ABSORPTIVE CELLS OF MAMMALIAN SMALL INTESTINE

  1972cited by this paper
• STUDIES ON MICROPEROXISOMES II. A CYTOCHEMICAL METHOD FOR LIGHT AND ELECTRON MICROSCOPY

  1972cited by this paper
• Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Alteration of 20∶5n−3 and 22∶6n−3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout

  2004cites this paper
• Micronized Fenofibrate: A New Fibric Acid Hypolipidemic Agent

  1999cites this paper
• Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate.

  1996cites this paper
• Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk.

  1996cites this paper
• Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes.

  1995cites this paper
• Relationship between plasma lipids and palmitoyl‐CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates

  1994cites this paper
• Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.

  1993cites this paper
• Hepatic peroxisome proliferation in rodents and its significance for humans.

  1993cites this paper
• Interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (PPAR): a molecular modelling and quantitative structure-activity relationship (QSAR) study.

  1993cites this paper
• Chemical Structure-Activity Relationships: Peroxisome Proliferation and Lipid Regulation in Rats

  1992cites this paper
• Peroxisome induction potential and lipid-regulating activity in rats. Quantitative microscopy and chemical structure-activity relationships.

  1991cites this paper
• Effects of fibrates on serum lipids and atherosclerosis.

  1988cites this paper
• Chemically induced proliferation of peroxisomes: implications for risk assessment.

  1988cites this paper
• Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.

  1988cites this paper
• Induction of peroxisomal fatty acyl-CoA oxidase and microsomal laurate hydroxylase activities by beclobric acid and two metabolites in primary cultures of rat hepatocytes.

  1987cites this paper
• Interspecies Differences in Peroxisomes and Peroxisome Proliferation

  1987cites this paper
• Subcellular localization and capacity of beta-oxidation and aldehyde dehydrogenase in porcine liver.

  1987cites this paper
• Examination of the structural requirements for proliferation of peroxisomes and mitochondria in mouse liver by hypolipidemic agents, with special emphasis on structural analogues of 2-ethylhexanoic acid.

  1987cites this paper